The Role of Radiologists in the Diagnosis and Management of HHT

June is HHT Awareness Month, a time to raise awareness of hereditary hemorrhagic telangiectasia (HHT), a genetic disorder affecting the blood vessels. A team of experts from UCSF Radiology and Pediatrics wrote a review published in Radiology on the role of radiologists in the diagnosis and management of HHT.

Novel Approaches for Diagnosing and Treating HHT

As a leading practitioner and medical innovator specializing in the management of vascular abnormalities, Dr. Steven Hetts brings an extraordinary skill set together to bridge clinical treatment and leading-edge technology development for managing hereditary hemorrhagic telangiectasia (HHT.)

UCSF Named Center of Excellence for Hereditary Hemorrhagic Telangiectasia

As Northern California’s only facility that specializes in the diagnosis and treatment of hereditary hemorrhagic telangiectasia (HHT), UCSF has been named a Center of Excellence by the HHT Foundation International, Inc!